Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 15, No 6 (2019) Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice Abstract  similar documents
D. A. Napalkov
"... of antihypertensive and hypolipidemic therapy with fixed combinations of indapamide/perindopril, amlodipine ..."
 
Vol 15, No 2 (2019) Modern Recommendations and Real Clinical Practice: the Results of the SILA Study Abstract  similar documents
O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin
"... Aim. To assess efficacy and safety of single-pill combination (SPC) amlodipine/perindopril ..."
 
Vol 9, No 5 (2013) THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL Abstract  similar documents
A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva
"... Aim. To evaluate the therapeutic equivalence between generic perindopril (Parnavel, LLC Ozone ..."
 
Vol 7, No 4 (2011) PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY Abstract  similar documents
O. V. Dralova, M. L. Maksimov
"... problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... perindopril,rosuvastatin and fixed-dose combination of perindopril and indapamide, in ambulatory patients ..."
 
Vol 13, No 2 (2017) COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH Abstract  similar documents
O. M. Drapkina
"... with perindopril (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid ..."
 
Vol 13, No 3 (2017) TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 Abstract  similar documents
O. M. Drapkina, A. S. Luishuta
"... Aim. To study the antihypertensive and hypolipidemic effect of therapy based on perindopril ..."
 
Vol 6, No 4 (2010) COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE Abstract  similar documents
O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova
"... Aim. To evaluate influence of the combined therapy with ACE inhibitor (perindopril), diuretic ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... adjusting individual treatment depending on clinical conditions. The composition of perindopril ..."
 
Vol 7, No 3 (2011) COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY Abstract  similar documents
O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko
"... Aim. To compare effects of perindopril and losartan potassium on the parameters of the ambulatory ..."
 
Vol 6, No 2 (2010) COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION Abstract  similar documents
Yu. I. Grinshtein, O. L. Barbarash, D. A. Yakhontov, A. E. Popelysheva, V. V. Shabalin, N. B. Osetrova
"... Aim. To compare efficacy of enalapril and perindopril in patients with arterial hypertension (HT ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
 
Vol 2, No 2 (2006) THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM Abstract  similar documents
I. G. Fomina, N. A. Galanina, Z. O. Georgadze, N. E. Gaidamakina
"... Aim. To study the influence of long-term therapy with perindopril on the heart inotropic function ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... Aim. To study the clinical and hemodynamic efficacy of monotherapy with ACE inhibitor perindopril ..."
 
Vol 7, No 6 (2011) COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... in groups A, B or C. Patients of group A (n=25) received a fixed combination of the original perindopril ..."
 
Vol 3, No 4 (2007) RESULTS AND COMMENTS ON ADVANCE STUDY Abstract  similar documents
S. R. Gilyarevsky
"... Влияние сочетанного применения фиксированной комбинации периндоприла и индапамида на частоту ..."
 
Vol 4, No 2 (2008) ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION Abstract  similar documents
M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva
"... Aim. To study effects of ACE inhibitor perindopril on markers of endothelial dysfunction ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... therapy with valsartan (n=20), 80–160 mg/day , or perindopril (n=21), 5–10 mg/day , in combination ..."
 
Vol 5, No 5 (2009) THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES Abstract  similar documents
S. V. Malchikova, E. I. Tarlovskaya
"... indapamide retard plus perindopril; group B - indapamide retard plus amlodipine; group C - amlodipine plus ..."
 
Vol 8, No 5 (2012) EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov
"... to moderate DM type 2 were included into the study. The patients were treated with perindopril (5–10 mg/day ..."
 
Vol 8, No 5 (2012) ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE Abstract  similar documents
M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina
"... on received drugs: perindopril and ivabradine - group 1; perindopril, bisoprolol and ivabradine - group 2 ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... of ACE inhibitors (ramipril, perindopril), which are associated with vasoprotection. ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... препарата Тритаце® у больных артериальной гипертонией (АГ) 1-2-й степени с высоким сердечно-сосудистым ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
"... . However this property can not be extended to all ACE inhibitors. Only ramipril and perindopril have ..."
 
Vol 7, No 4 (2011) USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, A. V. Rudakov, T. S. Zhupanova
"... степени с высоким и очень высоким риском сосудистых осложнений при назначении фиксированной комбинации ..."
 
Vol 7, No 5 (2011) AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION Abstract  similar documents
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva
"... . Результаты. В основной группе отмечено снижение артериального давления на 17,1±5,8/11,4±4,0 мм рт.ст. (p<0 ..."
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... высоким нормальным артериальным давлением (АД) (424 мужчины и 574 женщины; возраст 57,4±0,4 лет ..."
 
Vol 14, No 5 (2018) The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness Abstract  similar documents
E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova
"... with SPC (perindopril arginine/indapamide or valsartan/amlodipine) achieved the target BP level (<140/90 mm ..."
 
Vol 1, No 3 (2005) COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS Abstract  similar documents
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin
"... of combined drug of ACE inhibitors and diuretic. 25 patients took NF (perindopril 4 mg and indapamide 1,25 mg ..."
 
Vol 15, No 2 (2019) Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice Abstract  similar documents
E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova
"... dose combinations in Vladivostok polyclinics was performed. Two-component (perindopril + amlodipine ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... in patients without left ventricle dysfunction are demonstrated in studies EUROPA with perindopril 8 mg ..."
 
Vol 4, No 1 (2008) VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES Abstract  similar documents
E. D. Golovanova
"... and perindopril (Noliprel Forte, 1 tab/d: perindopril 4 mg and indapamide 1,25 mg) on pulse wave velocity (PWV ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... the number of recommendations of enalapril increased up to 50.8%, perindopril – up to 24.1%. Analysis ..."
 
Vol 3, No 3 (2007) REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS Abstract  similar documents
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
"... пациентов с высоким риском монотерапия Энамом (эналаприл, Д-р Редди’с) способствует снижению артериального ..."
 
Vol 10, No 1 (2014) SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE) Abstract  similar documents
R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. Veldhuisen van, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt
"... . Исследование ставило целью оценить безопасность и эффективность эплеренона у пациентов с высоким риском ..."
 
Vol 14, No 1 (2018) PROBLEMS OF EVALUATING BLOOD PRESSURE MEASUREMENT IN MODERN CLINICAL TRIALS (THE CASE OF SPRINT STUDY RESULTS) Abstract  similar documents
V. M. Gorbunov
"... мм рт.ст. у пациентов с высоким риском сердечно-сосудистых осложнений (ССО). В исследование был ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS Abstract  similar documents
O. L. Barbarash, M. V. Zykov
"... 100-150 мг, если не был достигнут целевой уровень АД менее 140/90 мм рт.ст. (менее 130/80 мм рт.ст ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... осложнений. Рассмотрены эффективность и безопасность терапии высокими дозами аторвастатина. Показано, что ..."
 
Vol 14, No 2 (2018) THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT Abstract  similar documents
M. S. Soboleva, Е. E. Loskutova
"... .6% to 27%), lisinopril (from 4.4% to 23.9%) and perindopril (from 0.9% to 7.8%); among calcium channel ..."
 
Vol 8, No 6 (2012) MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE Abstract  similar documents
V. M. Gorbunov
"... in patients of amlodipine/perindopril treatment group was significantly lower than this in patients ..."
 
Vol 5, No 4 (2009) TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONS Abstract  similar documents
S. V. Malchikova, E. I. Tarlovskaya
"... /perindopril; group B - indapamide retard/amlodipine; group C – amlodipine/lisinopril; group D – amlodipine ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... гипертензией (АГ) высокого риска является важнейшей задачей в плане снижения заболеваемости и смертности от ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... антагониста кальция амлодипина у лиц с артериальной гипертонией (АГ) и высоким сердечно-сосудистым риском ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... антиагрегантного, но и других биологических эффектов. Цель. Сравнить влияние поддерживающего лечения высокой и ..."
 
Vol 2, No 4 (2006) FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS Abstract  similar documents
Yu. M. Lopatin
"... ангиотензинпревращающего фермента (иАПФ) рамиприла больным высокого сердечно-сосудистого риска приводит к улучшению ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... терапии с риском развития неблагоприятных событий, а также факторы, обуславливающие высокую остаточную ..."
 
Vol 8, No 1 (2012) THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov
"... сравнительном рандомизированном исследовании оценена эффективность терапии высокой дозой симвастатина (40 мг ..."
 
Vol 10, No 5 (2014) CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE Abstract  similar documents
S. V. Gatsura, O. A. Gatsura, A. N. Golosova
"... was Noliprel, perindopril/indapamide fixed combination, – 14.0% and 13.7% of respondents in 2011-12 and 2013-14 ..."
 
Vol 16, No 1 (2020) High Blood Pressure Variability is an Additional Cardiovascular Risk Factor Abstract  similar documents
A. V. Rodionov
"... можно рассматривать как одну из самостоятельных целей терапии. Для пациентов с высокой вариабельностью ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... офисного АД с 161,8±18,6/93,9±8,9 мм рт.ст. до 137,3±12,2/84,1±6,5 мм рт.ст. (p<0,05). Наблюдалась ..."
 
Vol 5, No 3 (2009) COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) Abstract  similar documents
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova
"... (общий холестерин [ОХС], триглицериды [ТГ], холестерин липопротеидов высокой плотности [ХС ЛПВП], глюкоза ..."
 
Vol 15, No 2 (2019) Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov
"... . When choosing ACEI, priority was given to perindopril, with which no one randomized clinical trial ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... Отечественные врачи нередко опасаются назначать статины пациентам высокого сердечно-сосудистого ..."
 
Vol 6, No 4 (2010) RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
M. V. Ezhov
"... Представлены результаты исследований последних лет по эффективности высоких доз аторвастатина при ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... печени у больных с сердечно-сосудистыми заболеваниями (ССЗ) и высоким риском сердечно-сосудистых ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... с высоким риском сердечно-сосудистых осложнений. Материал и методы. За период с 1 мая по 31 декабря ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
"... , описаны белки, регулирующие его транспорт. Особое внимание уделено роли липопротеидов высокой плотности ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... ведению больных с высоким сердечно-сосудистым риском; 2) распространенное мнение об изолированном ..."
 
Vol 16, No 1 (2020) Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease Abstract  PDF (Eng)  similar documents
O. A. Koshelskaya, T. E. Suslova, I. V. Kologrivova, N. Y. Margolis, O. A. Zhuravleva, O. A. Kharitonova, I. V. Vinnitskaya
"... -ЛПВП+0,28×вчСРБ (ТГ – триглицериды, ХС-ЛПВП – холестерин липопротеинов высокой плотности). Если ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... препаратами статинов, назна- чаемых пациентам с высоким и очень высоким риском развития сердечно-сосудистых ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... пациентов высокого и очень высокого сердечно-сосудистого риска за период 2011-2015 гг. Материал и методы. В ..."
 
Vol 6, No 6 (2010) ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE Abstract  similar documents
A. A. Kudryavtsev, A. S. Ryazanov, N. N. Eremenko, S. A. Kireev
"... (снижение со 172,4±1,62 до 129,8±3,4 мм рт.ст.) через 12 нед лечения (p<0,05). Отмечена высокая частота ..."
 
Vol 14, No 5 (2018) Orthostatic Hypotension: Definition, Pathophysiology, Classification, Prognostic Aspects, Diagnostics and Treatment Abstract  similar documents
O. D. Ostroumova, M. S. Cherniaeva, M. M. Petrova, O. V. Golovina
"... ее высокой  распространенностью и неблагоприятным влиянием на прогноз и качество жизни пациентов ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... ,001). Продемонстрирована высокая приверженность терапии УДХК. Заключение. Комбинированная терапия статинами и УДХК ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
 
Vol 15, No 6 (2019) Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach Abstract  similar documents
М. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, D. A. Volkov, N. V. Furman, P. V. Dolotovskaya
"... , клиническое АД меньше 140 и 90 мм рт.ст., отсутствие когда-либо диагноза АГ и приема любых антигипертензивных ..."
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... , спланированных для оценки эффективности применения высоких доз статинов перед чрескожными коронарными ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... Высокая распространённость артериальной гипертонии в сочетании с высоким и очень высоким сердечно ..."
 
Vol 8, No 2 (2012) SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY Abstract  similar documents
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa
"... немассивной ТЭЛА, 13 (20%) из которых отнесены к высокому риску летального исхода по критериям ESC, а 51 (80 ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... ревматоидным артритом (РА). Материал и методы. Обследовали 130 женщин с высокой активностью РА. Контрольную ..."
 
Vol 2, No 3 (2006) COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS Abstract  similar documents
O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova
"... в профилактике сердечно-сосудистых осложнений, особенно у пациентов из группы высокого риска. ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 4, No 4 (2008) INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK Abstract  similar documents
N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky
 
Vol 12, No 3 (2016) EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva
"... толщину комплекса интима-медиа (ТКИМ). Результаты. Больные с ИАГ >30 эпизодов/час имели более высокие ..."
 
Vol 13, No 6 (2017) BLOOD PRESSURE PHENOTYPES IN TREATED HYPERTENSIVE PATIENTS IN SUMMER AND WINTER: FOCUS ON MASKED UNCONTROLLED HYPERTENSION. Part 2. The main markers Abstract  PDF (Eng)  similar documents
M. I. Smirnova, V. M. Gorbunov, S. A. Boytsov, M. M. Loukianov, A. M. Kalinina, D. A. Volkov, A. D. Deev, Ya. N. Koshelyaevskaya, E. N. Belova
"... , обследованных в Иваново и Саратове (n=477), отобраны больные с клиническим АД <140/90 мм рт.ст. на регулярной ..."
 
Vol 6, No 6 (2010) THE EVALUATION OF COMPLIANCE TO ANTIHYPERTENSIVE THERAPY IN PATIENTS AFTER STROKE AND POSTSTROKE DEPRESSION DURING ANTIDEPRESSANT THERAPY Abstract  similar documents
B. B. Fishman, A. I. Khoroshevskaya, A. A. Abdulin, G. G. Semenova, P. V. Starikov, O. V. Pavlova
"... /90 мм рт.ст.) и субклинической постинсультной депрессией после прохождения стационарной ..."
 
Vol 2, No 4 (2006) CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY Abstract  similar documents
R. I. Striuk
"... высокого и низкого риска. Подробно описаны немедикаментозные методы ведения беременных с АГ . У пациенток ..."
 
Vol 15, No 4 (2019) Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study) Abstract  PDF (Eng)  similar documents
Yu. A. Balanova, S. A. Shalnova, A. E. Imaeva, А. V. Kapustina, G. A. Muromtseva, S. V. Evstifeeva, V. I. Tarasov, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, S. S. Yakushin, S. A. Boytsov, O. M. Drapkina
"... определялась при уровне систолического артериального давления (САД)≥140 мм рт.ст. и/или диастолического ..."
 
Vol 10, No 5 (2014) THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION Abstract  similar documents
M. I. Smirnova, E. M. Platonova, A. N. Britov, V. M. Gorbunov, A. D. Deev, Y. N. Koshelyaevskaya
"... ,5 года) отобраны лица (n=185) с нормальным офисным АД <140 и <90 мм рт.ст.. Проводился стандартный опрос ..."
 
Vol 14, No 3 (2018) ACUTE DECOMPENSATION OF HYPERTENSIVE HEART DISEASE IN PATIENT WITH MALIGNANT URINARY BLADDER PARAGANGLIOMA: STAGES OF DIAGNOSTICS AND TREATMENT Abstract  similar documents
O. V. Blagova, I. N. Alijeva, E. A. Bezrukov, L. I. Ippolitov, G. V. Polunin, E. A. Kogan, V. V. Sedov, E. A. Mershina, V. E. Sinitsyn, N. D. Sarkisova, A. V. Nedostup, V. V. Fomin
"... . ст.). Клиническая картина включала стойкую артериальную гипертензию (180-220 и 120-150 мм рт.ст ..."
 
Vol 5, No 3 (2009) EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS Abstract  similar documents
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko
"... регуляцию системы кровообращения у больных АГ. При исходно высоком уровне систолического артериального ..."
 
Vol 15, No 6 (2019) Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) Abstract  similar documents
O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova
"... (САД) (117 против 107 мм рт.ст.), диастолического АД (ДАД) (67 против 56 мм рт.ст.), среднего АД (81 ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... предикторы ее эффективности у пациентов очень высокого сердечно-сосудистого риска. Материал и методы. В ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
 
Vol 8, No 4 (2012) RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS  similar documents
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
"... высоким сердечно-сосудистым риском с критериями включения, аналогичными исследованию HOPE (Heart Outcomes ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... контрольной группы более высокими значениями минимальной (52,3±0,4 против 47,5±0,4; p<0,001) и средней (78,5±0 ..."
 
Vol 14, No 6 (2018) Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk Abstract  PDF (Eng)  similar documents
O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk
"... и рамиприла у пациентов с артериальной гипертонией и очень высоким сердечно-сосудистым риском ..."
 
Vol 5, No 3 (2009) ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT Abstract  similar documents
V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko
"... лечения лизиноприлом и симвастатином у пациентов со средним или высоким риском сердечно-сосудистых ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... , возраст 64,0±1,8 года) с холестерином липопротеинов низкой плотности (ХС ЛПНП) ≥3,0 ммоль/л с высоким ..."
 
Vol 4, No 5 (2008) EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
 
Vol 15, No 6 (2019) Prospects for Blood Pressure Remote Monitoring in Hypertensive Patients in the Ryazan Region Abstract  similar documents
N. V. Aksenova, A. A. Nizov, O. N. Selyavina, E. I. Suchkova, E. V. Filippov
"... /85 мм рт.ст. у 70% больных. Доля пациентов с высоким уровнем нормального АД увеличилась с 10% до 19 ..."
 
Vol 12, No 6 (2016) POSSIBLE CHANGES IN THE CENTRAL HEMODYNAMICS IN PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS OF VIRAL ETIOLOGY WITH DIFFERENT LEVELS OF CYTOKINES Abstract  similar documents
V. E Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... давления в ней до 35,7Ѓ}3,1 мм рт.ст. Частота и варианты изменений структурно-функциональных параметров ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... ацетилсалициловой кислоты (АСК), выпускаемых в виде таблеток в кишечнорастворимой оболочке, у больных высокого риска ..."
 
Vol 3, No 3 (2007) MAXIMAL REDUCTION OF CARDIOVASCULAR COMPLICATIONS RISK – THE MAIN TASK OF MODERN THERAPY FOR HIGH RISK PATIENTS. RANDOMIZED STUDY ON COMPREHENSIVE CONTROL ON ARTERIAL HYPERTENSION AND DYSLIPIDAEMIA Abstract  similar documents
N. P. Kutishenko, V. V. Yakusevich, A. A. Seragzim, A. D. Deev, S. Y. Martsevich
"... больных высокого риска. Рандомизированное исследование по комплексной медикаментозной коррекции ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
 
Vol 12, No 4 (2016) New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) Abstract  similar documents
Article Editorial
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... происходящих изменений в оказании медикаментозной помощи пациентам с высоким и очень высоким риском сердечно ..."
 
1 - 100 of 466 Items 1 2 3 4 5 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)